StockData
Accustem Sciences Inc. logo

Accustem Sciences Inc. (ACUT) stock

ACUTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.15+0.00 (0.00%)

Close on Oct 16, 2026Market cap $2.37MP/E –Yield –

Accustem Sciences gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Accustem Sciences

Accustem Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Accustem Sciences figures

See a number that looks wrong?